-
Enric Domingo
Department of Oncology, University of Oxford, Oxford, UK.
-
Sanjay Rathee
Department of Oncology, Medical Sciences Division, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford, OX3 7DQ, UK.
-
Andrew Blake
Department of Oncology, University of Oxford, Oxford, UK.
-
Leslie Samuel
Department of Clinical Oncology, Aberdeen Royal Infirmary, Aberdeen, UK.
-
Graeme Murray
School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, UK.
-
David Sebag-Montefiore
Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, United Kingdom; Radiotherapy Research Group, Leeds Institute of Medical Research, University of Leeds, United Kingdom.
-
Simon Gollins
North Wales Cancer Treatment Centre, Besti Cadwaladr University Health Board, Bodelwyddan, Denbighshire, LL18 5UJ, UK.
-
Nicholas West
Leeds Institute of Medical Research, University of Leeds, LS9 7TF, UK.
-
Rubina Begum
Cancer Research & University College London Clinica Trial Unit, London, United Kingdom.
-
Susan Richman
Leeds Institute of Medical Research, University of Leeds, LS9 7TF, UK.
-
Phil Quirke
Department of Pathology and Tumour Biology, Leeds Institute of Cancer and Pathology, Leeds, UK.
-
Keara Redmond
The Patrick G Johnston Centre for Cancer Research, Queens University Belfast, Belfast, BT7 9AE, UK.
-
Aikaterini Chatzipli
Wellcome Trust Sanger Institute, Hinxton, UK.
-
Alessandro Barberis
Nuffield Department of Surgical Sciences, Medical Sciences Division, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford, OX3 7DQ, UK. dr.alessandro.barberis@gmail.com.
-
Sylvana Hassanieh
Department of Oncology, Medical Sciences Division, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford, OX3 7DQ, UK.
-
Umair Mahmood
Department of Oncology, Medical Sciences Division, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford, OX3 7DQ, UK.
-
Michael Youdell
Department of Oncology, Medical Sciences Division, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford, OX3 7DQ, UK.
-
Ultan McDermott
Wellcome Trust Sanger Institute, Hinxton, UK.
-
Viktor Koelzer
Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland; Department of Oncology and Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
-
Simon Leedham
Wellcome Trust Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, UK.
-
Ian Tomlinson
Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway; Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, UK.
-
Philip Dunne
The Patrick G Johnston Centre for Cancer Research, Queens University Belfast, Belfast, BT7 9AE, UK.
-
Francesca M Buffa
Computational Biology and Integrative Genomics Lab, Department of Oncology, Medical Sciences Division, University of Oxford, Oxford, OX3 7DQ, UK. francesca.buffa@unibocconi.it.
-
Timothy S Maughan
Department of Oncology, Medical Sciences Division, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford, OX3 7DQ, UK; Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK. Electronic address: tim.maughan@oncology.ox.ac.uk.